This tender is from the country of Serbia in Europe region. The tender was published by "TORLAK" INSTITUTE FOR VIRUSOLOGY, VACCINES AND SERUMS on 26 Feb 2026 for Procurement of eggs - starting biological raw materials for production and control of flu vaccine. The last date to submit your bid for this tender was 26 Feb 2026. This tender is for the companies specializing in General anti-infectives for systemic use and vaccines and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
"TORLAK" INSTITUTE FOR VIRUSOLOGY, VACCINES AND SERUMS
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33651000 : General anti-infectives for systemic use and vaccines
Tender Document Type:
Tender Notice
Tender Description:
Procurement of eggs - starting biological raw materials for production and control of flu vaccine
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in General anti-infectives for systemic use and vaccines? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Defence sector in Serbia, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Serbia is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33651000, enabling precise filtering. Search by:
While you're viewing a tender in Serbia, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Defence, Serbia, and General anti-infectives for systemic use and vaccines categories.